Docoh
Loading...

BHSE Bull Horn

Document And Entity Information

Document And Entity Information - shares9 Months Ended
Sep. 30, 2021Nov. 16, 2021
Document Information Line Items
Entity Registrant NameBULL HORN HOLDINGS CORP.
Trading SymbolBHSE
Document Type10-Q
Current Fiscal Year End Date--12-31
Entity Common Stock, Shares Outstanding9,375,000
Amendment Flagfalse
Entity Central Index Key0001759186
Entity Current Reporting StatusYes
Entity Filer CategoryNon-accelerated Filer
Document Period End DateSep. 30,
2021
Document Fiscal Year Focus2021
Document Fiscal Period FocusQ3
Entity Small Businesstrue
Entity Emerging Growth Companytrue
Entity Shell Companytrue
Entity Ex Transition Periodfalse
Document Quarterly Reporttrue
Document Transition Reportfalse
Entity File Number001-39669
Entity Incorporation, State or Country CodeD8
Entity Tax Identification Number98-1465952
Entity Address, Address Line One801 S. Pointe Drive
Entity Address, Address Line TwoSuite TH-1
Entity Address, City or TownMiami Beach
Entity Address, State or ProvinceFL
Entity Address, Postal Zip Code33139
City Area Code(305)
Local Phone Number671-3341
Title of 12(b) SecurityOrdinary Shares, par value $0.0001 per share
Security Exchange NameNASDAQ
Entity Interactive Data CurrentYes

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)Sep. 30, 2021Dec. 31, 2020
ASSETS
Cash $ 584,634 $ 907,184
Prepaid expenses and other current assets18,670 51,815
Total Current Assets603,304 958,999
Marketable securities held in Trust Account75,756,871 75,751,204
TOTAL ASSETS76,360,175 76,710,203
Current liabilities
Accounts payable and accrued expenses46,471 5,000
Total Current Liabilities46,471 5,000
Warrant liabilities3,862,500 20,700,000
Deferred underwriting fee payable2,250,000 2,250,000
Total Liabilities6,158,971 22,955,000
Commitments
Ordinary shares subject to redemption, 7,500,000 shares at redemption value as of September 30, 2021 and December 31, 202075,756,871 75,751,204
Shareholders’ Deficit
Preferred shares, no par value; unlimited shares authorized; none issued and outstanding
Ordinary shares, no par value; unlimited shares authorized; 1,875,000 shares issued and outstanding (excluding 7,500,000 shares subject to possible redemption) at September 30, 2021 and December 31, 202025,000 25,000
Accumulated deficit(5,580,667)(22,021,001)
Total Shareholders’ Deficit(5,555,667)(21,996,001)
TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT $ 76,360,175 $ 76,710,203

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares9 Months Ended12 Months Ended
Sep. 30, 2021Dec. 31, 2020
Statement of Financial Position [Abstract]
Ordinary shares subject to possible redemption7,500,000 7,500,000
Preferred shares, par value (in Dollars per share)
Preferred shares, authorizedUnlimitedUnlimited
Preferred shares, issued
Preferred shares, outstanding
Ordinary shares, par value (in Dollars per share)
Ordinary shares, authorizedUnlimitedUnlimited
Ordinary shares, issued1,875,000 1,875,000
Ordinary shares, outstanding1,875,000 1,875,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)3 Months Ended9 Months Ended
Sep. 30, 2021Sep. 30, 2020Sep. 30, 2021Sep. 30, 2020
Income Statement [Abstract]
Operating and formation costs $ 100,017 $ 50 $ 397,223 $ 498
Loss from operations(100,017)(50)(397,223)(498)
Other income:
Interest earned on marketable securities held in Trust Account1,910 5,667
Change in fair value of private warrants liabilities4,275,000 16,837,500
Other interest income16 57
Other income4,276,926 16,843,224
Net income (loss) $ 4,176,909 $ (50) $ 16,446,001 $ (498)
Basic and diluted weighted average shares outstanding, ordinary shares (in Shares)9,375,000 9,375,000
Basic and diluted net income per ordinary share (in Dollars per share) $ 0.45 $ 0 $ 1.75 $ 0

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders’ Equity - USD ($)Ordinary SharesAccumulated DeficitTotal
Balance at Dec. 31, 2019 $ 25,000 $ (9,307) $ 15,693
Balance (in Shares) at Dec. 31, 20192,156,250
Net income (loss) 2 2
Balance at Mar. 31, 2020 $ 25,000 (9,305)15,695
Balance (in Shares) at Mar. 31, 20202,156,250
Balance at Dec. 31, 2019 $ 25,000 (9,307)15,693
Balance (in Shares) at Dec. 31, 20192,156,250
Balance at Dec. 31, 2020 $ 25,000 (22,021,001)(21,996,001)
Balance (in Shares) at Dec. 31, 20201,875,000
Balance at Mar. 31, 2020 $ 25,000 (9,305)15,695
Balance (in Shares) at Mar. 31, 20202,156,250
Net income (loss) (450)(450)
Balance at Jun. 30, 2020 $ 25,000 (9,755)15,245
Balance (in Shares) at Jun. 30, 20202,156,250
Net income (loss) (50)(50)
Balance at Sep. 30, 2020 $ 25,000 (9,805)15,195
Balance (in Shares) at Sep. 30, 20202,156,250
Balance at Dec. 31, 2020 $ 25,000 (22,021,001)(21,996,001)
Balance (in Shares) at Dec. 31, 20201,875,000
Accretion for ordinary shares to redemption amount (1,868)(1,868)
Net income (loss) 14,072,850 14,072,850
Balance at Mar. 31, 2021 $ 25,000 (7,950,019)(7,925,019)
Balance (in Shares) at Mar. 31, 20211,875,000
Accretion for ordinary shares to redemption amount (1,889)1,803,765
Net income (loss) (1,803,758)(1,803,758)
Balance at Jun. 30, 2021 $ 25,000 (9,755,666)(9,730,666)
Balance (in Shares) at Jun. 30, 20211,875,000
Accretion for ordinary shares to redemption amount (1,910)(1,910)
Net income (loss) 4,176,909 4,176,909
Balance at Sep. 30, 2021 $ 25,000 $ (5,580,667) $ (5,555,667)
Balance (in Shares) at Sep. 30, 20211,875,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)9 Months Ended
Sep. 30, 2021Sep. 30, 2020
Cash Flows from Operating Activities:
Net income (loss) $ 16,446,001 $ (498)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account(5,667)
Change in fair value of warrant liabilities(16,837,500)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets33,145
Accounts payable and accrued expenses41,471 (450)
Net cash used in operating activities(322,550)(948)
Cash Flows from Financing Activities:
Proceeds from promissory note – related party 22,527
Repayment of promissory note – related party (21,777)
Net cash provided by financing activities 750
Net Change in Cash(322,550)(198)
Cash – Beginning907,184 505
Cash – Ending584,634 307
Non-cash investing and financing activities:
Change in value of ordinary shares subject to redemption5,667
Offering costs included in accrued offering costs 5,000
Deferred underwriting fees $ 2,250,000

Description of Organization and

Description of Organization and Business Operations9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONSNOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Bull
Horn Holdings Corp. (the “Company”) is a blank check company incorporated in the British Virgin Islands on November 27, 2018.
The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing
all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination
with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry
or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the sports (including
sports franchises or assets related to sports franchises and sports technology), entertainment and brands sectors. As
of September 30, 2021, the Company had not yet commenced any operations. All activity through September 30, 2021 relates to the Company’s
formation, its initial public offering (the “Initial Public Offering”) and identifying a target company for a Business Combination. The
registration statement for the Initial Public Offering was declared effective on October 29, 2020. On November 3, 2020, the Company consummated
the Initial Public Offering of 7,500,000 units (the “Units” and, with respect to the ordinary shares of the Company (the
“ordinary shares”) included in the Units sold, the “Public Shares”) at $10.00 per Unit, generating gross proceeds
of $75,000,000. Each Unit consists of an ordinary shares and one redeemable warrant (the “Public Warrants”). See Note 4. Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 3,750,000 warrants (the “Private Placement
Warrants”) at a price of $1.00 per Private Warrant in a private placement to the Company’s sponsor, Bull Horn Holdings Sponsor
LLC (the “Sponsor”), Imperial Capital, LLC (“Imperial”), I-Bankers Securities, Inc. (“I-Bankers”)
and Northland Securities, Inc. (“Northland”) (and their designees), generating gross proceeds of $3,750,000, which is described
in Note 5. Each of these Private Placement Warrants allow the holder thereof to purchase one ordinary share. Transaction
costs amounted to $4,243,264 consisting of $1,500,000 of underwriting fees, $2,250,000 of deferred underwriting fees and $493,264 of
other offering costs. Following
the closing of the Initial Public Offering on November 3, 2020, an amount of $75,750,000 ($10.10 per Unit) from the net proceeds of the
sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust
Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less,
or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the
distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that
together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions
and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will
only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting
securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect
a Business Combination. The
Company will provide its public shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion
of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination
at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against
a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least
$5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a
majority of the outstanding shares voted are voted in favor of the Business Combination. If
the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules,
the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any
affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined
under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking
redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent. The
shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially
$10.10 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company
to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced
by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption
rights upon the completion of a Business Combination with respect to the Company’s warrants. If
a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the
Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender
offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the
same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The
Sponsor and any of the Company’s officers or directors that may hold founder shares (the “initial shareholders”), Imperial
and I-Bankers have agreed (a) to vote their founder shares, and any Public Shares purchased during or after the Initial Public Offering
in favor of a Business Combination, (b) not to propose an amendment to the Company’s Memorandum and Articles of Association with
respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company
provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c)
not to redeem any shares (including the founder shares) into the right to receive cash from the Trust Account in connection with a shareholder
vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company
does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Memorandum and Articles of Association
relating to shareholders’ rights of pre-Business Combination activity and (d) that the founder shares shall not participate in
any liquidating distributions upon winding up if a Business Combination is not consummated. However, the initial shareholders will be
entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial
Public Offering if the Company fails to complete its Business Combination. The
Company will have until May 3, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable
to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public
Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest
earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding
Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to
receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence
a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims
of creditors and the requirements of applicable law. The underwriters of the Initial Public Offering have agreed to waive its rights
to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within
the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the amount initially funded in the Trust Account ($10.10 per share). The
Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amounts in the Trust Account to below $10.10 per share (whether or not the underwriters’ over-allotment option is exercised
in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and
except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed
waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such
third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to
claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which
the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies
held in the Trust Account. Risks
and Uncertainties Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that COVID-19 and variants
thereof, and governmental and societal actions to manage the pandemic, could have a negative effect on the Company’s financial
position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date
of the accompanying unaudited condensed financial statements. The accompanying unaudited condensed financial statements do not include
any adjustments that might result from the outcome of this uncertainty.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements9 Months Ended
Sep. 30, 2021
Condensed Financial Information Disclosure [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTSNOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL
STATEMENTS In connection with the preparation
of the Company’s financial statements as of September 30, 2021, management identified errors made in its historical financial statements
where, at the closing of the Company’s Initial Public Offering, the Company improperly valued its ordinary shares subject to possible
redemption. The Company previously determined the ordinary shares subject to possible redemption to be equal to the redemption value,
while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined
that the Public Shares underlying the Units issued during the Initial Public Offering can be redeemed or become redeemable subject to
the occurrence of future events considered outside the Company’s control. Therefore, management concluded that the redemption value
should include Public Shares subject to possible redemption, resulting in the Public Shares subject to possible redemption being equal
to their redemption value. As a result, management has noted a classification error related to temporary equity and permanent equity.
This resulted in a restatement to the initial carrying value of the ordinary shares subject to possible redemption with the offset recorded
to ordinary shares and accumulated deficit. The impact of the restatement
on the Company’s financial statement is reflected in the following table.
As
Previously Adjustment As
Restated
Balance Sheet as of November 3, 2020
Ordinary shares
subject to possible redemption $ 65,919,462 $ 9,830,538 $ 75,750,000
Ordinary shares $ 5,124,824 $ (5,099,824 ) $ 25,000
Accumulated deficit $ (124,815 ) $ (4,730,714 ) $ (4,855,529 )
Total shareholders’ equity
(deficit) $ 5,000,009 $ (9,830,538 ) $ (4,830,529 )
Number of shares subject to
redemption 6,526,679 973,321 7,500,000
Balance Sheet as of December
31, 2020
Ordinary shares subject to
possible redemption $ 48,755,202 $ 26,996,002 $ 75,751,204
Ordinary shares $ 22,289,084 $ (22,264,084 ) $ 25,000
Accumulated deficit $ (17,289,083 ) $ (4,731,918 ) $ (22,021,001 )
Total shareholders’ equity
(deficit) $ 5,000,001 $ (26,996,002 ) $ (21,996,001 )
Number of shares subject to
redemption 4,827,171 2,672,829 7,500,000
Balance Sheet as of March
31, 2021
Ordinary shares subject to
possible redemption $ 62,828,052 $ 12,925,020 $ 75,753,072
Ordinary shares $ 8,216,234 $ (8,191,234 ) $ 25,000
Accumulated deficit $ (3,216,233 ) $ (4,733,786 ) $ (7,950,019 )
Total shareholders’ equity
(deficit) $ 5,000,001 $ (12,925,020 ) $ (7,925,019 )
Number of shares subject to
redemption 6,220,347 1,279,653 7,500,000
Balance Sheet as of June 30,
2021
Ordinary shares subject to
possible redemption $ 61,024,287 $ 14,730,674 $ 75,754,961
Ordinary shares $ 10,019,999 $ (9,994,999 ) $ 25,000
Accumulated deficit $ (5,019,991 ) $ (4,735,675 ) $ (9,755,666 )
Total shareholders’ equity
(deficit) $ 5,000,008 $ (14,730,674 ) $ (9,730,666 )
Number of shares subject to
redemption 6,041,613 1,458,387 7,500,000
As
Previously Adjustment As
Restated
Statement of Operations for
the Period Ended December 31, 2020
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 6,526,679 (6,526,679 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption $ — $ — $ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 2,029,242 (2,029,242 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ (8.52 ) $ 8.52 $ —
Weighted average ordinary shares outstanding — 3,063,525 3,063,525
Basic and diluted net loss
per share ordinary share $ — $ (5.64 ) $ (5.64 )
Statement of Operations for
the Three Months Ended March 31, 2021
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 4,827,171 (4,827,171 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption — — —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 4,547,829 (4,547,829 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ 3.09 $ (3.09 ) $ —
Weighted average ordinary shares outstanding — 9,375,000 9,375,000
Basic and diluted net loss
per share ordinary share $ — $ 1.50 $ 1.50
Statement of Operations for
the Three Months Ended June 30, 2021
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 6,220,347 (6,220,347 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption $ — $ — $ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 3,154,653 (3,154,653 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ (0.57 ) $ 0.57 $ —
Weighted average ordinary shares outstanding — 9,375,000 9,375,000
Basic and diluted net loss
per share ordinary share $ — $ (0.19 ) $ (0.19 )
Statement of Operations for
the Six Months Ended June 30, 2021
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 5,527,608 (5,527,608 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption $ — $ — $ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 5,248,266 (5,248,266 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ 2.34 $ (2.34 ) $ —
Weighted average ordinary shares outstanding — 9,375,000 9,375,000
Basic and diluted net loss
per share ordinary share $ — $ 1.31 $ 1.31
Statement
of Changes in Shareholders’ Equity (Deficit) for the Period Ended December 31, 2020
Sale of 7,500,000 Units, net
of underwriting discounts $ 69,069,286 (69,069,286 ) —
Contribution in excess of fair
value on sale of 3,750,000 Private Placement Warrants 1,950,000 (1,950,000 ) —
Ordinary shares subject to
possible redemption $ (71,019,286 ) 71,019,286 —
Accretion for ordinary shares
subject to redemption amount $ — (6,681,918 ) (6,681,918 )
Total shareholders’ equity
(deficit) $ 5,000,001 (26,996,002 ) (21,996,001 )
Statement
of Changes in Shareholders’ Equity (Deficit) for the Three Months ended March 31, 2021
Ordinary shares subject to
possible redemption (14,072,850 ) 14,072,850 —
Accretion for ordinary share
subject to redemption amount $ — (1,868 ) (1,868 )
Total shareholders’ equity
(deficit) $ 5,000,001 (12,925,020 ) (7,925,019 )
Statement
of Changes in Shareholders’ Equity (Deficit) for the Three Months ended June 30, 2021
Ordinary shares subject to
possible redemption (1,803,765 ) 1,803,765 —
Accretion for ordinary share
subject to redemption value — (1,889 ) (1,889 )
Total shareholders’ equity
(deficit) 5,000,008 (14,730,674 ) (9,730,666 )
Statement of Cash Flows for
the Period Ended December 31, 2020
Initial classification of ordinary
shares subject to possible redemption 65,919,462 (9,830,538 ) 75,750,000
Change in value of ordinary
shares subject to possible redemption (17,164,260 ) 17,165,464 1,204
Statement of Cash Flows for
the Three Months Ended March 31, 2021
Change in value of ordinary
shares subject to possible redemption 14,072,850 (14,069,778 ) 3,072
Statement of Cash Flows for
the Six Months Ended June 30, 2021
Change in value of ordinary
shares subject to possible redemption 12,269,085 (12,264,124 ) 4,961

Summary of Significant Accounti

Summary of Significant Accounting Policies9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESNOTE
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis
of Presentation The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q
and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote
disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the
rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes
necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the
accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary
for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed
financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A as filed with the SEC on March
31, 2021 and amended on July 28, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily
indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. Emerging
Growth Company The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute
payments not previously approved. Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used. Use
of Estimates The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may
be subject to change as more current information becomes available and accordingly the actual results could differ significantly from
those estimates. Cash
and Cash Equivalents The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020. Marketable
Securities Held in Trust Account At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest primarily in U.S. Treasury securities. The Company’s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined
using available market information. Ordinary
Shares Subject to Possible Redemption The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are
classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares
that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified
as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside
of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible
redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s
balance sheets. The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary
shares are affected by charges against ordinary shares and accumulated deficit. At
September 30, 2021 and December 31, 2020, the ordinary shares reflected in the condensed balance sheets are reconciled in the
following table:
Gross proceeds $ 75,000,000
Less:
Proceeds allocated to Public Warrants (1,800,000 )
Ordinary shares issuance costs (4,130,714 )
Plus:
Accretion of carrying value to redemption value 6,681,918
Ordinary shares subject to possible redemption, 12/31/20 75,751,204
Accretion of carrying value to redemption value 5,667
Ordinary shares subject to possible redemption, 9/30/21 $ 75,756,871 Warrant
Liabilities The
Company accounts for the Public Warrants and Private Placement Warrants (together with the Public Warrants, the “Warrants”)
in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must
be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants
to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants
are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public
Warrants for periods where no observable traded price was available are valued using a binomial lattice simulation model. For periods
subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value
as of each relevant date. Income
Taxes The
Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset
and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed
for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible
amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.
Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is
the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits,
if any, as income tax expense. There were no unrecognized tax benefits as of September 30, 2021 and December 31, 2020 and no amounts
accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position. The
Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations
may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with
foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change
over the next twelve months. The
Company is considered to be an exempted British Virgin Islands company with no connection to any other taxable jurisdiction and is presently
not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. Net
Income (Loss) per Ordinary Share The Company complies with
accounting and disclosure requirements of Financial Accounting Standards Board’s (“FASB”) ASC Topic 260, “Earnings
Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary
shares outstanding for the period. Accretion associated with the redeemable shares of ordinary shares is excluded from earnings per share
as the redemption value approximates fair value. The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events.
The Public Warrants are exercisable to purchase 7,500,000 ordinary shares in the aggregate. As of September 30, 2021 and 2020,
the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary
shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic
net income (loss) per ordinary share for the periods presented. The
following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):
Three Months Ended Nine Months Ended
2021 2020 2021 2020
Basic and diluted net loss per common share
Numerator:
Allocation of net loss, as adjusted $ 4,176,909 (50 ) 16,446,001 (498 )
Denominator:
Basic and diluted weighted average shares outstanding 9,375,000 1,875,000 9,375,000 1,875,000
Basic and diluted net loss per common share $ 0.45 $ (0.00 ) $ 1.75 $ (0.00 ) Concentration
of Credit Risk Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account. Fair
Value of Financial Instruments The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value
Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their
short-term nature, except for warrant liabilities (see Note 10). Recently
Issued Accounting Standards In
August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options
(Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible
Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments
by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required
for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation
in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of ASU 2020-06 did not impact the Company’s financial
position, results of operations or cash flows. Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the accompanying condensed financial statements.

Initial Public Offering

Initial Public Offering9 Months Ended
Sep. 30, 2021
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERINGNOTE
4. INITIAL PUBLIC OFFERING Pursuant
to the Initial Public Offering, the Company sold 7,500,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one ordinary
share and one Public Warrant. Each Public Warrant entitles the holder to purchase one-half of one ordinary share at an exercise price
of $11.50 per whole share, subject to adjustment (see Note 9).

Private Placement

Private Placement9 Months Ended
Sep. 30, 2021
Private Placement [Abstract]
PRIVATE PLACEMENTNOTE
5. PRIVATE PLACEMENT Simultaneously
with the closing of the Initial Public Offering, the Sponsor and the underwriters of the Initial Public Offering (Imperial, I-Bankers
and Northland (and their designees)) purchased an aggregate of 3,750,000 Private Placement Warrants at a price of $1.00 per Private Placement
Warrant, of which 2,625,000 Private Placement Warrants were purchased by the Sponsor and 1,125,000 Private Placement Warrants were purchased
by Imperial, I-Bankers and Northland ($3,750,000 in the aggregate). The Sponsor, Imperial, I-Bankers and Northland agreed to purchase
up to an additional 337,500 Private Placement Warrants at a price of $1.00 per Private Warrant, or an aggregate of $337,500, in the case
that the underwriters’ over-allotment option is exercised in full or in part (such over-allotment option was never exercised).
Each of these Private Placement Warrants allow the holder thereof to purchase one ordinary share. The proceeds from the sale of the Private
Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. The Private Placement Warrants
are identical to the Public Warrants sold in the Initial Public Offering, except that the Private Placement Warrants allow the holder
thereof to one ordinary share and as further described in Note 9. If the Company does not complete a Business Combination within the
Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares
(subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Related Party Transactions

Related Party Transactions9 Months Ended
Sep. 30, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONSNOTE
6. RELATED PARTY TRANSACTIONS Founder
Shares In
November 2018, in anticipation of the expected issuance of 2,156,250 founder shares to the Sponsor, the Sponsor paid certain of the Company’s
deferred offering costs with the $25,000 purchase price of the founder shares. As of December 31, 2018, one founder share was issued
to the Sponsor. The remaining 2,156,249 founder shares were issued to the Sponsor on January 28, 2019. The
2,156,250 founder shares included an aggregate of up to 281,250 shares subject to forfeiture by the Sponsor to the extent that the underwriters’
over-allotment was not exercised in full or in part, so that the initial shareholders would collectively own 20% of the Company’s
issued and outstanding shares after the Initial Public Offering (assuming the initial shareholders do not purchase any Public Shares
in the Initial Public Offering). On December 10, 2020, the underwriters notified the Company that they would not be exercising the over-allotment
option and as a result, the Sponsor returned 281,250 founder shares to the Company for no consideration and such founder shares were
canceled. The
initial shareholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees)
until, with respect to 50% of the founder shares, the earlier of (i) six months after the date of the consummation of a Business Combination,
or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for
stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing
after a Business Combination, and, with respect to the remaining 50% of the founder shares, upon six months after the date of the consummation
of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation,
merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange
their ordinary shares for cash, securities or other property. Assignment
of Private Placement Warrants Effective
December 10, 2020, by agreements between the Sponsor, Imperial, I-Bankers and Northland, an aggregate of 375,000 Private Placement Warrants
were assigned by Imperial, I-Bankers and Northland to the Sponsor. Promissory
Note — Related Party On
November 18, 2018, as amended on December 23, 2019, the Company issued an unsecured promissory note (the “Promissory Note”)
to the Sponsor, pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The note was non-interest
bearing and payable on the earlier of (i) December 31, 2020 or (ii) the consummation of the Initial Public Offering. The outstanding
balance under the Promissory Note of $194,830 was repaid at the closing of the Initial Public Offering on November 3, 2020. There are
no further borrowings available under the Promissory Note. Related
Party Loans In
order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor,
or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working
Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation
of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation
of a Business Combination into additional Private Placement Warrants at a price of $1.00 per Private Warrant. In the event that a Business
Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans
but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2021 and December 31,
2020, there were no amounts outstanding under the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIESNOTE
7. COMMITMENTS AND CONTINGENCIES Anchor
Investors Six
unaffiliated qualified institutional buyers (who are also not affiliated with the Sponsor or any member of the Company’s management
team) purchased Units in the Initial Public Offering at a level of 9.9% of the Units subject to the Initial Public Offering (which aggregates
to 59.4% of the Units subject to the Initial Public Offering) and entered into subscription agreements with the Sponsor to memorialize
their agreement. The Company refers to these investors as “anchor investors.” In consideration of providing these agreements,
the anchor investors each purchased membership interests in the Sponsor, for nominal consideration, entitling them to an interest in
an aggregate of 270,000 founder shares held by the Sponsor or 45,000 founder shares for each anchor investor (which the Company refers
to as the “anchor founder shares”). The anchor founder shares are treated the same in all material respects as the founder
shares held by the Sponsor, except (i) such investors will forfeit their anchor founder shares if they do not purchase a number of Units
equal to 9.9% of the number Units sold in the Initial Public Offering and (ii) such anchor founder shares shall have the right not to
be subject to adjustments or cutbacks in the event the Sponsor agrees to any such adjustments or cutbacks (of its shares) in connection
with the initial Business Combination. Discussions with each anchor investor were separate and the arrangements with them are not contingent
on each other. Further, to the Company’s knowledge, the anchor investors are not affiliated with each other and are not acting
together with regards to the Company. The amount of the fair value of subscription agreements with the anchor investors in excess of
the amount paid was treated as contributed capital and offering costs related to the Initial Public Offering. Pursuant
to the subscription agreements with the Sponsor, the anchor investors have not been granted any material additional shareholder or other
rights, and are only being issued membership interests in the Sponsor with no right to control the Sponsor or vote or dispose of the
anchor founder shares (which will continue to be held by the Sponsor until following the initial Business Combination). Further, the
anchor investors are not required to: (i) hold any Units, ordinary shares or warrants they may purchase in the Initial Public Offering
or thereafter for any amount time, (ii) vote any ordinary shares they may own at the applicable time in favor of the initial Business
Combination or (iii) refrain from exercising their right to redeem their ordinary shares at the time of the initial Business Combination.
The purchases by the anchor investors of Units in the Initial Public Offering or the Company’s securities in the open market (or
both) could, if they hold such securities, allow the anchor investors or any one of them to assert influence over the Company, including
with respect to the initial Business Combination. Registration
Rights Pursuant
to a registration rights agreement entered into on October 29, 2020, the holders of the founder shares, the Private Placement Warrants
and underlying securities, and any securities issued upon conversion of Working Capital Loans (and underlying securities) will be entitled
to registration rights pursuant to a registration rights agreement. The holders of at least a majority in interest of the then-outstanding
number of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.
In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the consummation of a Business Combination. Notwithstanding the foregoing, Imperial, I-Bankers and Northland may not exercise their
demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration
statement and may not exercise its demand rights on more than one occasion. The registration rights agreement does not contain liquidating
damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear
the expenses incurred in connection with the filing of any such registration statements. Underwriting
Agreement The
underwriters are entitled to a deferred fee of three percent (3.0%) of the gross proceeds of the Initial Public Offering, or $2,250,000.
The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject
to the terms of the underwriting agreement.

Shareholders_ Equity

Shareholders’ Equity9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]
SHAREHOLDERS’ EQUITYNOTE
8. SHAREHOLDERS’ EQUITY Preferred
Shares Ordinary
Shares 1,8750,000

Warrants

Warrants9 Months Ended
Sep. 30, 2021
Warrants [Abstract]
WARRANTSNOTE
9. WARRANTS The
Public Warrants will become exercisable on the later of (a) the consummation of a Business Combination or (b) 12 months from the effective
date of the registration statement relating to the Initial Public Offering. No Public Warrants will be exercisable for cash unless the
Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants
and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary
shares issuable upon the exercise of the Public Warrants is not effective within 90 days from the consummation of a Business Combination,
the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed
to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption
from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise
their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination
or earlier upon redemption or liquidation. In
addition, if (x) the Company issues additional shares or equity-linked securities for capital raising purposes in connection with the
closing of its Business Combination at an issue price or effective issue price of less than $9.50 per share (as adjusted for splits,
dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) (with such issue price or effective issue
price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor,
initial shareholders or their affiliates, without taking into account any founder shares held by them prior to such issuance) (the “Newly
Issued Price”)), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and
interest thereon, available for the funding of the Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the
Company consummates its Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price
of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued
Price, and the $16.50 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 165% of
the higher of (i) the Market Value and (ii) the Newly Issued Price. The
Company may call the warrants for redemption (excluding the Private Placement Warrants), in whole and not in part, at a price of $0.01
per warrant:
● at
any time while the Public Warrants are exercisable, ● upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder, ● if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.50 per share, for any 20 trading days within a 30 trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and ● if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the
Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary
shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary
dividend or recapitalization, reorganization, merger or consolidation. However, except as described above, the warrants will not be adjusted
for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash
settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates
the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will
they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly,
the warrants may expire worthless. The
Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that
the Private Placement Warrants only allow the holder thereof to one ordinary share and the ordinary shares issuable upon the exercise
of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business
Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis
and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants
are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable
by the Company and exercisable by such holders on the same basis as the Public Warrants. ASC
Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants,
and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s
ordinary share. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s ordinary share if the terms of the warrant
require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based
on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s
Private Placement Warrants and Public Warrants are not indexed to the Company’s ordinary share in the manner contemplated by ASC
Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares.
In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded
that certain warrant provisions preclude equity treatment as by ASC Section 815-10-15. The
Company accounts for its Public Warrants and Private Placement Warrants as liabilities as set forth in ASC 815-40-15-7D and 7F. See Note
10 for details over the methodology and valuation of the Warrants.

Fair Value Measurements

Fair Value Measurements9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTSNOTE
10. FAIR VALUE MEASUREMENTS The
Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are re-measured and reported at fair value
at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The
fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:
Level
1: Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level
2: Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.
Level
3: Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The
following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September
30, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description Level September 30, December 31,
Assets:
Marketable securities held in Trust Account 1 $ 75,756,871 $ 75,751,204
Liabilities:
Warrant Liability – Public Warrants 1 $ 1,950,000 $ 10,350,000
Warrant Liability – Private Placement Warrants 3 $ 1,912,500 $ 10,350,000 The
Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying
condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair
value presented in the condensed statements of operations. Level
3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities
such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized
within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The
fair value of the Private Placement Warrants was estimated at September 30, 2021 and December 31, 2020 to be $.51 and $2.76, respectively,
using the modified Black-Scholes option pricing model and the following assumptions:
September 30, December 31,
Risk-free interest rate 0.88 % 0.39 %
Trading days per year 252 252
Expected volatility 10.9 % 34.4 %
Exercise price $ 11.50 $ 11.50
Stock Price $ 9.95 $ 10.19 The
following table presents the changes in the fair value of Level 3 warrant liabilities:
Private Placement
Fair value as of December 31, 2020 $ 10,350,000
Change in fair value (8,437,500 )
Fair value as of September 30, 2021 $ 1,912,500 There
were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and nine months ended September
30, 2021.

Subsequent Events

Subsequent Events9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTSNOTE
11. SUBSEQUENT EVENTS The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. The Company did not identify any other subsequent events that would have required adjustment or disclosure in the condensed
financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]
Basis of PresentationBasis
of Presentation The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q
and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote
disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the
rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes
necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the
accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary
for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed
financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A as filed with the SEC on March
31, 2021 and amended on July 28, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily
indicative of the results to be expected for the year ending December 31, 2021 or for any future periods.
Emerging Growth CompanyEmerging
Growth Company The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute
payments not previously approved. Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use of EstimatesUse
of Estimates The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may
be subject to change as more current information becomes available and accordingly the actual results could differ significantly from
those estimates.
Cash and Cash EquivalentsCash
and Cash Equivalents The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.
Marketable Securities Held in Trust AccountMarketable
Securities Held in Trust Account At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest primarily in U.S. Treasury securities. The Company’s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined
using available market information.
Ordinary Shares Subject to Possible RedemptionOrdinary
Shares Subject to Possible Redemption The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are
classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares
that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified
as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside
of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible
redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s
balance sheets. The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary
shares are affected by charges against ordinary shares and accumulated deficit. At
September 30, 2021 and December 31, 2020, the ordinary shares reflected in the condensed balance sheets are reconciled in the
following table:
Gross proceeds $ 75,000,000
Less:
Proceeds allocated to Public Warrants (1,800,000 )
Ordinary shares issuance costs (4,130,714 )
Plus:
Accretion of carrying value to redemption value 6,681,918
Ordinary shares subject to possible redemption, 12/31/20 75,751,204
Accretion of carrying value to redemption value 5,667
Ordinary shares subject to possible redemption, 9/30/21 $ 75,756,871
Warrant LiabilityWarrant
Liabilities The
Company accounts for the Public Warrants and Private Placement Warrants (together with the Public Warrants, the “Warrants”)
in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must
be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants
to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants
are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public
Warrants for periods where no observable traded price was available are valued using a binomial lattice simulation model. For periods
subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value
as of each relevant date.
Income TaxesIncome
Taxes The
Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset
and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed
for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible
amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.
Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is
the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits,
if any, as income tax expense. There were no unrecognized tax benefits as of September 30, 2021 and December 31, 2020 and no amounts
accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position. The
Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations
may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with
foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change
over the next twelve months. The
Company is considered to be an exempted British Virgin Islands company with no connection to any other taxable jurisdiction and is presently
not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States.
Net Income (Loss) per Ordinary ShareNet
Income (Loss) per Ordinary Share The Company complies with
accounting and disclosure requirements of Financial Accounting Standards Board’s (“FASB”) ASC Topic 260, “Earnings
Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary
shares outstanding for the period. Accretion associated with the redeemable shares of ordinary shares is excluded from earnings per share
as the redemption value approximates fair value. The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events.
The Public Warrants are exercisable to purchase 7,500,000 ordinary shares in the aggregate. As of September 30, 2021 and 2020,
the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary
shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic
net income (loss) per ordinary share for the periods presented. The
following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):
Three Months Ended Nine Months Ended
2021 2020 2021 2020
Basic and diluted net loss per common share
Numerator:
Allocation of net loss, as adjusted $ 4,176,909 (50 ) 16,446,001 (498 )
Denominator:
Basic and diluted weighted average shares outstanding 9,375,000 1,875,000 9,375,000 1,875,000
Basic and diluted net loss per common share $ 0.45 $ (0.00 ) $ 1.75 $ (0.00 )
Concentration of Credit RiskConcentration
of Credit Risk Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial InstrumentsFair
Value of Financial Instruments The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value
Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their
short-term nature, except for warrant liabilities (see Note 10).
Recently Issued Accounting StandardsRecently
Issued Accounting Standards In
August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options
(Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible
Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments
by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required
for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation
in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of ASU 2020-06 did not impact the Company’s financial
position, results of operations or cash flows. Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the accompanying condensed financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)9 Months Ended
Sep. 30, 2021
Condensed Financial Information Disclosure [Abstract]
Schedule of the restatement on the company’s financial statementsAs
Previously Adjustment As
Restated
Balance Sheet as of November 3, 2020
Ordinary shares
subject to possible redemption $ 65,919,462 $ 9,830,538 $ 75,750,000
Ordinary shares $ 5,124,824 $ (5,099,824 ) $ 25,000
Accumulated deficit $ (124,815 ) $ (4,730,714 ) $ (4,855,529 )
Total shareholders’ equity
(deficit) $ 5,000,009 $ (9,830,538 ) $ (4,830,529 )
Number of shares subject to
redemption 6,526,679 973,321 7,500,000
Balance Sheet as of December
31, 2020
Ordinary shares subject to
possible redemption $ 48,755,202 $ 26,996,002 $ 75,751,204
Ordinary shares $ 22,289,084 $ (22,264,084 ) $ 25,000
Accumulated deficit $ (17,289,083 ) $ (4,731,918 ) $ (22,021,001 )
Total shareholders’ equity
(deficit) $ 5,000,001 $ (26,996,002 ) $ (21,996,001 )
Number of shares subject to
redemption 4,827,171 2,672,829 7,500,000
Balance Sheet as of March
31, 2021
Ordinary shares subject to
possible redemption $ 62,828,052 $ 12,925,020 $ 75,753,072
Ordinary shares $ 8,216,234 $ (8,191,234 ) $ 25,000
Accumulated deficit $ (3,216,233 ) $ (4,733,786 ) $ (7,950,019 )
Total shareholders’ equity
(deficit) $ 5,000,001 $ (12,925,020 ) $ (7,925,019 )
Number of shares subject to
redemption 6,220,347 1,279,653 7,500,000
Balance Sheet as of June 30,
2021
Ordinary shares subject to
possible redemption $ 61,024,287 $ 14,730,674 $ 75,754,961
Ordinary shares $ 10,019,999 $ (9,994,999 ) $ 25,000
Accumulated deficit $ (5,019,991 ) $ (4,735,675 ) $ (9,755,666 )
Total shareholders’ equity
(deficit) $ 5,000,008 $ (14,730,674 ) $ (9,730,666 )
Number of shares subject to
redemption 6,041,613 1,458,387 7,500,000
As
Previously Adjustment As
Restated
Statement of Operations for
the Period Ended December 31, 2020
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 6,526,679 (6,526,679 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption $ — $ — $ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 2,029,242 (2,029,242 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ (8.52 ) $ 8.52 $ —
Weighted average ordinary shares outstanding — 3,063,525 3,063,525
Basic and diluted net loss
per share ordinary share $ — $ (5.64 ) $ (5.64 )
Statement of Operations for
the Three Months Ended March 31, 2021
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 4,827,171 (4,827,171 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption — — —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 4,547,829 (4,547,829 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ 3.09 $ (3.09 ) $ —
Weighted average ordinary shares outstanding — 9,375,000 9,375,000
Basic and diluted net loss
per share ordinary share $ — $ 1.50 $ 1.50
Statement of Operations for
the Three Months Ended June 30, 2021
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 6,220,347 (6,220,347 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption $ — $ — $ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 3,154,653 (3,154,653 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ (0.57 ) $ 0.57 $ —
Weighted average ordinary shares outstanding — 9,375,000 9,375,000
Basic and diluted net loss
per share ordinary share $ — $ (0.19 ) $ (0.19 )
Statement of Operations for
the Six Months Ended June 30, 2021
Basic and diluted weighted
average shares outstanding, ordinary shares subject to possible redemption 5,527,608 (5,527,608 ) —
Basic and diluted net income
per share, Ordinary shares stock subject to possible redemption $ — $ — $ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock 5,248,266 (5,248,266 ) —
Basic and diluted net loss
(income) per share, Non-redeemable common stock $ 2.34 $ (2.34 ) $ —
Weighted average ordinary shares outstanding — 9,375,000 9,375,000
Basic and diluted net loss
per share ordinary share $ — $ 1.31 $ 1.31
Statement
of Changes in Shareholders’ Equity (Deficit) for the Period Ended December 31, 2020
Sale of 7,500,000 Units, net
of underwriting discounts $ 69,069,286 (69,069,286 ) —
Contribution in excess of fair
value on sale of 3,750,000 Private Placement Warrants 1,950,000 (1,950,000 ) —
Ordinary shares subject to
possible redemption $ (71,019,286 ) 71,019,286 —
Accretion for ordinary shares
subject to redemption amount $ — (6,681,918 ) (6,681,918 )
Total shareholders’ equity
(deficit) $ 5,000,001 (26,996,002 ) (21,996,001 )
Statement
of Changes in Shareholders’ Equity (Deficit) for the Three Months ended March 31, 2021
Ordinary shares subject to
possible redemption (14,072,850 ) 14,072,850 —
Accretion for ordinary share
subject to redemption amount $ — (1,868 ) (1,868 )
Total shareholders’ equity
(deficit) $ 5,000,001 (12,925,020 ) (7,925,019 )
Statement
of Changes in Shareholders’ Equity (Deficit) for the Three Months ended June 30, 2021
Ordinary shares subject to
possible redemption (1,803,765 ) 1,803,765 —
Accretion for ordinary share
subject to redemption value — (1,889 ) (1,889 )
Total shareholders’ equity
(deficit) 5,000,008 (14,730,674 ) (9,730,666 )
Statement of Cash Flows for
the Period Ended December 31, 2020
Initial classification of ordinary
shares subject to possible redemption 65,919,462 (9,830,538 ) 75,750,000
Change in value of ordinary
shares subject to possible redemption (17,164,260 ) 17,165,464 1,204
Statement of Cash Flows for
the Three Months Ended March 31, 2021
Change in value of ordinary
shares subject to possible redemption 14,072,850 (14,069,778 ) 3,072
Statement of Cash Flows for
the Six Months Ended June 30, 2021
Change in value of ordinary
shares subject to possible redemption 12,269,085 (12,264,124 ) 4,961

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]
Schedue of the ordinary shares reflected in the condensed balance sheetsGross proceeds $ 75,000,000
Less:
Proceeds allocated to Public Warrants (1,800,000 )
Ordinary shares issuance costs (4,130,714 )
Plus:
Accretion of carrying value to redemption value 6,681,918
Ordinary shares subject to possible redemption, 12/31/20 75,751,204
Accretion of carrying value to redemption value 5,667
Ordinary shares subject to possible redemption, 9/30/21 $ 75,756,871
Schedule of calculation of basic and diluted net income (loss) per ordinary shareThree Months Ended Nine Months Ended
2021 2020 2021 2020
Basic and diluted net loss per common share
Numerator:
Allocation of net loss, as adjusted $ 4,176,909 (50 ) 16,446,001 (498 )
Denominator:
Basic and diluted weighted average shares outstanding 9,375,000 1,875,000 9,375,000 1,875,000
Basic and diluted net loss per common share $ 0.45 $ (0.00 ) $ 1.75 $ (0.00 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of the company's assets that are measured at fair value on a recurring basisDescription Level September 30, December 31,
Assets:
Marketable securities held in Trust Account 1 $ 75,756,871 $ 75,751,204
Liabilities:
Warrant Liability – Public Warrants 1 $ 1,950,000 $ 10,350,000
Warrant Liability – Private Placement Warrants 3 $ 1,912,500 $ 10,350,000
Schedule of black-scholes option pricing model and assumptionsSeptember 30, December 31,
Risk-free interest rate 0.88 % 0.39 %
Trading days per year 252 252
Expected volatility 10.9 % 34.4 %
Exercise price $ 11.50 $ 11.50
Stock Price $ 9.95 $ 10.19
Schedule of changes in the fair value of warrant liabilitiesPrivate Placement
Fair value as of December 31, 2020 $ 10,350,000
Change in fair value (8,437,500 )
Fair value as of September 30, 2021 $ 1,912,500

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)Nov. 03, 2020Sep. 30, 2021
Description of Organization and Business Operations (Details) [Line Items]
Transaction costs $ 4,243,264
Underwriting fees1,500,000
Deferred underwriting fees2,250,000
Other offering costs493,264
Initial public offering, descriptionFollowing
the closing of the Initial Public Offering on November 3, 2020, an amount of $75,750,000 ($10.10 per Unit) from the net proceeds of the
sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust
Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less,
or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the
distribution of the funds in the Trust Account to the Company’s shareholders, as described below. 
Net tangible assets $ 5,000,001
Percentage of seeking redemption rights15.00%
Pro rata price, per share (in Dollars per share) $ 10.1
Reduce price per share (in Dollars per share) $ 10.1
Series of Individually Immaterial Business Acquisitions [Member]
Description of Organization and Business Operations (Details) [Line Items]
Business combination, descriptionBusiness Combination must be with one or more target businesses that
together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions
and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will
only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting
securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act.
Private Warrants [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units of initial public offering (in Shares)3,750,000
Generating gross proceeds $ 3,750,000
Price per share (in Dollars per share) $ 1
Description of sale of stockEach of these Private Placement Warrants allow the holder thereof to purchase one ordinary share.
IPO [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units of initial public offering (in Shares)7,500,000
Per unit price (in Dollars per share) $ 10
Generating gross proceeds $ 75,000,000
Pro rata price, per share (in Dollars per share) $ 10
IPO [Member] | Series of Individually Immaterial Business Acquisitions [Member]
Description of Organization and Business Operations (Details) [Line Items]
Description of business combinationIf the Company is unable
to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public
Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest
earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding
Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to
receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence
a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims
of creditors and the requirements of applicable law. The underwriters of the Initial Public Offering have agreed to waive its rights
to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within
the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the amount initially funded in the Trust Account ($10.10 per share).

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details)9 Months Ended
Sep. 30, 2021USD ($)
Condensed Financial Information Disclosure [Abstract]
Net tangible assets $ 5,000,001

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of the restatement on the company’s financial statements - USD ($)3 Months Ended6 Months Ended12 Months Ended
Jun. 30, 2021Mar. 31, 2021Jun. 30, 2021Dec. 31, 2020Nov. 03, 2020
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Ordinary shares subject to possible redemption $ 61,024,287 $ 62,828,052 $ 61,024,287 $ 48,755,202 $ 65,919,462
Ordinary shares10,019,999 8,216,234 10,019,999 22,289,084 5,124,824
Accumulated deficit(5,019,991)(3,216,233)(5,019,991)(17,289,083)(124,815)
Total shareholders’ equity (deficit) $ 5,000,008 5,000,001 5,000,008 5,000,001 $ 5,000,009
Initial classification of ordinary shares subject to possible redemption65,919,462
Change in value of ordinary shares subject to possible redemption $ 14,072,850 $ 12,269,085 $ (17,164,260)
Number of shares subject to redemption (in Shares)6,041,613 6,220,347 6,041,613 4,827,171 6,526,679
Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares)6,220,347 4,827,171 5,527,608 6,526,679
Basic and diluted net income per share, Ordinary shares stock subject to possible redemption (in Dollars per share)
Basic and diluted weighted average shares outstanding, Non-redeemable common stock (in Shares)3,154,653 4,547,829 5,248,266 2,029,242
Basic and diluted net loss (income) per share, Non-redeemable common stock (in Dollars per share) $ (0.57) $ 3.09 $ 2.34 $ (8.52)
Weighted average ordinary shares outstanding (in Shares)
Basic and diluted net loss per share ordinary share (in Dollars per share)
Sale of 7,500,000 Units, net of underwriting discounts (in Shares)69,069,286
Contribution in excess of fair value on sale of 3,750,000 Private Placement Warrants $ 1,950,000
Ordinary shares subject to possible redemption $ (1,803,765) $ (14,072,850)(71,019,286)
Accretion for ordinary shares subject to redemption amount
Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Ordinary shares subject to possible redemption14,730,674 12,925,020 $ 14,730,674 26,996,002 $ 9,830,538
Ordinary shares(9,994,999)(8,191,234)(9,994,999)(22,264,084)(5,099,824)
Accumulated deficit(4,735,675)(4,733,786)(4,735,675)(4,731,918)(4,730,714)
Total shareholders’ equity (deficit) $ (14,730,674)(12,925,020)(14,730,674)(26,996,002) $ (9,830,538)
Initial classification of ordinary shares subject to possible redemption(9,830,538)
Change in value of ordinary shares subject to possible redemption $ (14,069,778) $ (12,264,124) $ 17,165,464
Number of shares subject to redemption (in Shares)1,458,387 1,279,653 1,458,387 2,672,829 973,321
Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares)(6,220,347)(4,827,171)(5,527,608)(6,526,679)
Basic and diluted net income per share, Ordinary shares stock subject to possible redemption (in Dollars per share)
Basic and diluted weighted average shares outstanding, Non-redeemable common stock (in Shares)(3,154,653)(4,547,829)(5,248,266)(2,029,242)
Basic and diluted net loss (income) per share, Non-redeemable common stock (in Dollars per share) $ 0.57 $ (3.09) $ (2.34) $ 8.52
Weighted average ordinary shares outstanding (in Shares)9,375,000 9,375,000 9,375,000 3,063,525
Basic and diluted net loss per share ordinary share (in Dollars per share) $ (0.19) $ 1.5 $ 1.31 $ (5.64)
Sale of 7,500,000 Units, net of underwriting discounts (in Shares)(69,069,286)
Contribution in excess of fair value on sale of 3,750,000 Private Placement Warrants $ (1,950,000)
Ordinary shares subject to possible redemption $ 1,803,765 $ 14,072,850 71,019,286
Accretion for ordinary shares subject to redemption amount(1,889)(1,868)(6,681,918)
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Ordinary shares subject to possible redemption75,754,961 75,753,072 $ 75,754,961 75,751,204 $ 75,750,000
Ordinary shares25,000 25,000 25,000 25,000 25,000
Accumulated deficit(9,755,666)(7,950,019)(9,755,666)(22,021,001)(4,855,529)
Total shareholders’ equity (deficit) $ (9,730,666)(7,925,019)(9,730,666)(21,996,001) $ (4,830,529)
Initial classification of ordinary shares subject to possible redemption75,750,000
Change in value of ordinary shares subject to possible redemption $ 3,072 $ 4,961 $ 1,204
Number of shares subject to redemption (in Shares)7,500,000 7,500,000 7,500,000 7,500,000 7,500,000
Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption (in Shares)
Basic and diluted net income per share, Ordinary shares stock subject to possible redemption (in Dollars per share)
Basic and diluted weighted average shares outstanding, Non-redeemable common stock (in Shares)
Basic and diluted net loss (income) per share, Non-redeemable common stock (in Dollars per share)
Weighted average ordinary shares outstanding (in Shares)9,375,000 9,375,000 9,375,000 3,063,525
Basic and diluted net loss per share ordinary share (in Dollars per share) $ (0.19) $ 1.5 $ 1.31 $ (5.64)
Sale of 7,500,000 Units, net of underwriting discounts (in Shares)
Contribution in excess of fair value on sale of 3,750,000 Private Placement Warrants
Ordinary shares subject to possible redemption
Accretion for ordinary shares subject to redemption amount $ (1,889) $ (1,868) $ (6,681,918)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)9 Months Ended
Sep. 30, 2021USD ($)shares
Accounting Policies [Abstract]
Aggregate ordinary shares | shares7,500,000
Amount of federal depository insurance coverage | $ $ 250,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedue of the ordinary shares reflected in the condensed balance sheets9 Months Ended
Sep. 30, 2021USD ($)
Schedue of the ordinary shares reflected in the condensed balance sheets [Abstract]
Gross proceeds $ 75,000,000
Less:
Proceeds allocated to Public Warrants(1,800,000)
Ordinary shares issuance costs(4,130,714)
Plus:
Accretion of carrying value to redemption value6,681,918
Ordinary shares subject to possible redemption, 12/31/2075,751,204
Accretion of carrying value to redemption value5,667
Ordinary shares subject to possible redemption, 9/30/21 $ 75,756,871

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income (loss) per ordinary share - USD ($)3 Months Ended9 Months Ended
Sep. 30, 2021Sep. 30, 2020Sep. 30, 2021Sep. 30, 2020
Numerator:
Allocation of net loss, as adjusted (in Dollars) $ 4,176,909 $ (50) $ 16,446,001 $ (498)
Denominator:
Basic and diluted weighted average shares outstanding9,375,000 1,875,000 9,375,000 1,875,000
Basic and diluted net loss per common share0.450 1.750

Initial Public Offering (Detail

Initial Public Offering (Details)9 Months Ended
Sep. 30, 2021$ / sharesshares
Initial Public Offering (Details) [Line Items]
Share price per share $ 10.1
Warrant [Member]
Initial Public Offering (Details) [Line Items]
Warrant exercise price $ 11.5
IPO [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock (in Shares) | shares7,500,000
Share price per share $ 10
Warrant descriptionEach Public Warrant entitles the holder to purchase one-half of one ordinary share at an exercise price
of $11.50 per whole share, subject to adjustment (see Note 9).

Private Placement (Details)

Private Placement (Details)9 Months Ended
Sep. 30, 2021$ / sharesshares
Private Placement (Details) [Line Items]
Price per warrant (in Dollars per share) | $ / shares $ 1
Additional aggregate public offering units337,500
Sponsor [Member]
Private Placement (Details) [Line Items]
Aggregate public offering units1,125,000
Imperial and I-Bankers [Member]
Private Placement (Details) [Line Items]
Aggregate public offering units3,750,000
Underwriters over-allotment exercised337,500
Private Placement Warrant [Member]
Private Placement (Details) [Line Items]
Aggregate public offering units3,750,000
Price per warrant (in Dollars per share) | $ / shares $ 1
Additional aggregate public offering units2,625,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)Dec. 10, 2020Nov. 03, 2020Jan. 28, 2019Nov. 30, 2018Sep. 30, 2021Dec. 23, 2019Nov. 18, 2018
Related Party Transactions (Details) [Line Items]
Aggregate principal amount (in Dollars) $ 300,000
Conversion of notes (in Dollars) $ 1,500,000
Warrants price (in Dollars per share) $ 1
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Aggregate shares issued2,156,249 2,156,250 2,156,250
Deferred offering costs (in Dollars) $ 25,000
Shares subject to forfeiture281,250
Percentage of issued and outstanding shares20.00%
Stock splits, descriptionThe
initial shareholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees)
until, with respect to 50% of the founder shares, the earlier of (i) six months after the date of the consummation of a Business Combination,
or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for
stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing
after a Business Combination, and, with respect to the remaining 50% of the founder shares, upon six months after the date of the consummation
of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation,
merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange
their ordinary shares for cash, securities or other property. 
Promissory Note - Related Party [Member]
Related Party Transactions (Details) [Line Items]
Aggregate principal amount (in Dollars) $ 300,000
Repayment of borrowings amount (in Dollars) $ 194,830
Over-Allotment Option [Member]
Related Party Transactions (Details) [Line Items]
Ordinary shares returned281,250
Private Placement Warrant [Member]
Related Party Transactions (Details) [Line Items]
Aggregate private warrants375,000

Commitments and Contingencies (

Commitments and Contingencies (Details)9 Months Ended
Sep. 30, 2021shares
Commitments and Contingencies (Details) [Line Items]
Number of units percentage9.90%
Underwriting agreement, descriptionThe
underwriters are entitled to a deferred fee of three percent (3.0%) of the gross proceeds of the Initial Public Offering, or $2,250,000.
The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject
to the terms of the underwriting agreement.
IPO [Member]
Commitments and Contingencies (Details) [Line Items]
Shares sale percentage9.90%
IPO [Member] | Subscription Agreements [Member]
Commitments and Contingencies (Details) [Line Items]
Shares sale percentage59.40%
Founder Share [Member]
Commitments and Contingencies (Details) [Line Items]
Interest an aggregate (in Shares)270,000
Founder shares held by the sponsor (in Shares)45,000

Shareholders_ Equity (Details)

Shareholders’ Equity (Details) - shares9 Months Ended12 Months Ended
Sep. 30, 2021Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Ordinary shares, share issued18,750,000 18,750,000
Ordinary shares, shares outstanding18,750,000 18,750,000
Ordinary shares subject to possible redemption7,500,000 7,500,000

Warrants (Details)

Warrants (Details)9 Months Ended
Sep. 30, 2021
Warrants [Abstract]
Business acquisition, description of acquired entityIn
addition, if (x) the Company issues additional shares or equity-linked securities for capital raising purposes in connection with the
closing of its Business Combination at an issue price or effective issue price of less than $9.50 per share (as adjusted for splits,
dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) (with such issue price or effective issue
price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor,
initial shareholders or their affiliates, without taking into account any founder shares held by them prior to such issuance) (the “Newly
Issued Price”)), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and
interest thereon, available for the funding of the Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the
Company consummates its Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price
of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued
Price, and the $16.50 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 165% of
the higher of (i) the Market Value and (ii) the Newly Issued Price. 
Description of public warrants for redemptionThe
Company may call the warrants for redemption (excluding the Private Placement Warrants), in whole and not in part, at a price of $0.01
per warrant: 
●at
any time while the Public Warrants are exercisable,
  ●upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder,    ●if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.50 per share, for any 20 trading days within a 30 trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and    ●if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

Fair Value Measurements (Detail

Fair Value Measurements (Details) - $ / shares9 Months Ended12 Months Ended
Sep. 30, 2021Dec. 31, 2020
Fair Value Disclosures [Abstract]
Warrant price per share $ 51 $ 2.76

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of the company's assets that are measured at fair value on a recurring basis - USD ($)Sep. 30, 2021Dec. 31, 2020
Level 1 [Member]
Assets:
Marketable securities held in Trust Account $ 75,756,871 $ 75,751,204
Liabilities:
Warrant Liability – Public Warrants1,950,000 10,350,000
Level 3 [Member]
Liabilities:
Warrant Liability – Private Placement Warrants $ 1,912,500 $ 10,350,000

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of black-scholes option pricing model and assumptions - $ / shares9 Months Ended12 Months Ended
Sep. 30, 2021Dec. 31, 2020
Schedule of black-scholes option pricing model and assumptions [Abstract]
Risk-free interest rate0.88%0.39%
Trading days per year252 days252 days
Expected volatility10.90%34.40%
Exercise price $ 11.5 $ 11.5
Stock Price $ 9.95 $ 10.19

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities - Private Placement [Member]9 Months Ended
Sep. 30, 2021USD ($)
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Fair value beginning $ 10,350,000
Change in fair value(8,437,500)
Fair value ending $ 1,912,500